Balyasny Asset Management LLC Astrazeneca PLC Call Options Transaction History

Balyasny Asset Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $1.46 Million - $1.67 Million	19,100 New	19,100 $1.49 Million
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $16.5 Million - $19.1 Million	-350,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $17 Million - $20.3 Million	350,000 New	350,000 $17.5 Million
Q3 2020 Nov 16, 2020	SELL	$53.07 - $61.1 $10.6 Million - $12.2 Million	-200,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $9.05 Million - $11.6 Million	-210,000 Reduced 51.22%	200,000 $10.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $24.9 Million - $28.4 Million	-715,000 Reduced 63.56%	410,000 $15.8 Million
Q1 2018 May 15, 2018	BUY	$32.97 - $36.63 $37.1 Million - $41.2 Million	1,125,000 New	1,125,000 $39.3 Million

1,359

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $206B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.